Eam Investors, LLC Pliant Therapeutics, Inc. Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 12, 2023
BUY
$18.73 - $36.26 $699,228 - $1.35 Million
37,332 Added 116.81%
69,292 $1.84 Million
Q1 2023

May 12, 2023
BUY
$18.73 - $36.26 $598,610 - $1.16 Million
31,960 New
31,960 $850,000
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $837,717 - $2.65 Million
109,220 New
109,220 $2.28 Million

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email